Trial site
Hoag Memorial Hospital
- 18running trials
- 7closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Endometrial cancer4 trials
- Head and neck cancer4 trials
- Ovarian cancer4 trials
- Atrial fibrillation2 trials
- Bladder cancer2 trials
- Childhood cancers2 trials
- Colorectal cancer2 trials
- Crohn's disease2 trials
- Prostate cancer2 trials
- Triple-negative breast cancer2 trials
- Type 1 diabetes2 trials
- and 12 more
- Phase
- Phase 26 trials
- Phase 36 trials
- Phase 15 trials
- Phase 1/22 trials
- Phase 2/32 trials
- Status
- Active, not recruiting11 trials
- Recruiting7 trials
- Completed6 trials
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC5 trials
- Hoffmann-La Roche3 trials
- Biosense Webster, Inc.2 trials
- ImmunityBio, Inc.2 trials
- Volastra Therapeutics, Inc.2 trials
- and 11 more
Running trials
Recruiting
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Recruiting
Recruiting
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Active, not recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer2 recruiting
- Lung cancer2 recruiting
- Type 1 diabetes2 recruiting
- Childhood cancers1 recruiting
- Crohn's disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Ovarian cancer1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
Completed
Completed
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Terminated
Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026